Free Trial

Novo Nordisk A/S (NVO) Earnings Date, Estimates & Call Transcripts

Novo Nordisk A/S logo
$85.00 -18.44 (-17.83%)
(As of 12/20/2024 05:45 PM ET)
Get Novo Nordisk A/S Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Novo Nordisk A/S and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

NVO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NVO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Novo Nordisk A/S Analyst EPS Estimates

Current Year EPS Consensus Estimate:$3.24 EPS
Next Year EPS Consensus Estimate: $4.01 EPS

Novo Nordisk A/S Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/7/2024Q2 2024$0.71$0.65 -$0.06$0.65$9.91B$9.82B
5/2/2024Q1 2024$0.77$0.83+$0.06$0.83$9.23B$9.52B
1/31/2024Q4 2023$0.66$0.71+$0.05$0.71$9.14B$9.51B
11/2/2023Q3 2023$0.69$0.73+$0.04$0.73-$8.58B
8/10/2023Q2 2023$0.3350$0.3150 -$0.02$1.26$8.44B$7.93B
5/4/2023Q1 2023$0.3175$0.3175-$1.27$7.86B$7.69B
2/1/2023Q4 2022$0.2025$0.2075+$0.0050$0.83$6.74B$6.60B

Novo Nordisk A/S Earnings - Frequently Asked Questions

Novo Nordisk A/S updated its FY 2024 earnings guidance on Wednesday, November, 6th. The company issued revenue guidance of $41.7 billion-$43.1 billion, compared to the consensus revenue estimate of $41.9 billion.

Novo Nordisk A/S (NYSE:NVO) has a recorded annual revenue of $270.58 billion.

Novo Nordisk A/S (NYSE:NVO) has a recorded net income of $12.15 billion. NVO has generated $3.09 earnings per share over the last four quarters.

Novo Nordisk A/S (NYSE:NVO) has a trailing price-to-earnings ratio of 27.51 and a forward price-to-earnings ratio of 26.23. The price/earnings-to-growth ratio is 1.37.

Novo Nordisk A/S's earnings are expected to grow from $3.24 per share to $4.01 per share in the next year, which is a 23.77% increase.

More Earnings Resources from MarketBeat



This page (NYSE:NVO) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners